Jeffrey James Ross - Jun 23, 2021 Form 3 Insider Report for Miromatrix Medical Inc. (MIRO)

Role
Chief Executive Officer
Signature
/s/ Elise B. Houser, Attorney-in-Fact
Stock symbol
MIRO
Transactions as of
Jun 23, 2021
Transactions value $
$0
Form type
3
Date filed
6/23/2021, 06:36 PM
Next filing
Jan 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MIRO Common Stock 204K Jun 23, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRO Series B Preferred Stock Jun 23, 2021 Common Stock 4.4K $7.50 Direct F1
holding MIRO Employee Stock Options (right to buy) Jun 23, 2021 Common Stock 35.4K $1.25 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 37.5K $1.25 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 41.3K $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 43.8K $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 33.7K $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 39.4K $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 100K $3.75 Direct F2
holding MIRO Employee Stock Option (right to buy) Jun 23, 2021 Common Stock 68.7K $3.75 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 N/A
F2 Fully vested.
F3 34,357 shares vested; 34,357 will vest on May 30, 2022.